معرفی
Richard Schulz serves as a Professor in the Department of Pharmacology within the Faculty of Medicine and Dentistry at the University of Alberta. His research program at the Heritage Medical Research Centre focuses on cardiovascular pathobiology, specifically matrix metalloproteinases (MMPs) and reactive nitrogen-oxygen species in heart disease mechanisms including ischemic injury, heart failure, and shock.
Educational Background:
- Bachelor of Science in Chemistry, University of Calgary (1982)
- Doctor of Philosophy in Pharmacology, University of Alberta (1989)
Research Focus: The Schulz Laboratory investigates oxidative stress-induced cardiac damage through intracellular MMP-2 activation. This novel mechanism involves proteolysis of critical proteins (troponin I, dystrophin, junctophilin-2, SERCA2a) within cardiac myocytes, leading to contractile dysfunction. Current work develops targeted pharmacotherapies including MMP inhibitors and reactive species scavengers to protect against ischemia-reperfusion injury and chemotherapy cardiotoxicity, employing advanced cardiovascular pharmacology and molecular techniques.
Publication Trends: Schulz's 2018-2022 publications reveal consistent focus on MMP-2's dual role in extracellular matrix and intracellular remodeling. Key themes include molecular mechanisms of doxorubicin cardiotoxicity, ischemia-reperfusion injury pathways, and translational applications of MMPs as biomarkers in sepsis and Chagas disease. His work bridges fundamental discoveries (e.g., MMP-2 cleavage of nucleolar histones affecting rRNA transcription) with clinical therapeutic development.
Mentorship and Collaborations: Dr. Schulz mentors PhD student Wesam Ferag Bassiouni and postdoctoral fellow Dr. Zabed Mahmud. His research is integrated across the University of Alberta through affiliations with the Cardiovascular Research Centre, Mazankowski Alberta Heart Institute, Cancer Research Institute of Northern Alberta, and Women and Children's Health Research Institute, facilitating multidisciplinary clinical-translational partnerships.
Laboratory Structure: Operating from the Heritage Medical Research Centre, the Schulz Lab maintains active collaborations in cardiology, oncology, and infectious disease research, supporting both mechanistic studies of oxidative stress pathways and development of novel cardioprotective strategies.
